Tower Cold Chain will soon open its new headquarters in Philadelphia.
Tower Cold Chain, a pharmaceutical thermal protection specialist, has completed its new headquarters in the Americas region, it announced on June 27, 2023. The facility will officially open on Sept. 12, 2023, according to a company press release.
The building, located in Philadelphia, Pa., is the latest facility offering design, laboratory, and testing capabilities in the development of its temperature-controlled solutions. Further, Tower Cold Chain hopes this expansion will serve as a hub of innovation and expertise and a place for stronger partnerships to develop in the cold chain logistics industry.
“We are thrilled to inaugurate our Cent[er] of Excellence in Philadelphia, which demonstrates our unwavering commitment to the Americas market,” said Niall Balfour, chief executive officer, Tower Cold Chain, in the press release. “This marks a significant step in Tower’s growth trajectory. As demand for robust, reliable, reusable pharmaceutical logistics continues to surge, our investment in strategic locations enables us to provide essential support for the seamless transportation of temperature-sensitive pharmaceutical and life-science products.”
Source: Tower Cold Chain
WMFTS’ BioPure to Showcase Single-Use Bioclamp with Refined Manufacturing at INTERPHEX 2025
April 1st 2025With advanced manufacturing, BioPure’s BioClamp connector is manufactured to be 13% lighter than the previous model, resulting in a 26% reduction in carbon dioxide emissions across the full lifecycle of the product.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.